[1] SEKHON B S,JAIRATH S.Prebiotics,probiotics and synbiotics:an overview[J].Journal of Pharmacy Education and Research,2010,1(2):13-36.
[2] SAZAWAL S,HIREMATH G,DHINGRA U,et al.Efficacy of probiotics in prevention of acute diarrhoea:a meta-analysis of masked,randomised,placebo-controlled trials[J].The Lancet Infectious Diseases,2006,6(6):374-382.
[3] VAN DER AA KÜHLE A,JESPERSEN L.The taxonomic position of
Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA,the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase Ⅱ gene[J].Systematic and Applied Microbiology,2003,26(4):564-571.
[4] EDWARDS-INGRAM L,GITSHAM P,BURTON N,et al.Genotypic and physiological characterization of
Saccharomyces boulardii,the probiotic strain of
Saccharomyces cerevisiae[J].Applied and Environmental Microbiology,2007,73(8):2458-2467.
[5] HENNEQUIN C,THIERRY A,RICHARD G F,et al.Microsatellite typing as a new tool for identification of
Saccharomyces cerevisiae strains[J].Journal of Clinical Microbiology,2001,39(2):551-559.
[6] CASTAGLIUOLO I,RIEGLER M F,VALENICK L,et al.
Saccharomyces boulardii protease inhibits the effects of
Clostridium difficile toxins A and B in human colonic mucosa[J].Infection and Immunity,1999,67(1):302-307.
[7] BUTS J P,DEKEYSER N,STILMANT C,et al.
Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits
Escherichia coli endotoxin by dephosphorylation[J].Pediatric Research,2006,60(1):24-29.
[8] CZERUCKA D,ROUX I,RAMPAL P.
Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells[J].Gastroenterology,1994,106(1):65-72.
[9] WU X,VALLANCE B A,BOYER L,et al.
Saccharomyces boulardii ameliorates
Citrobacter rodentium-induced colitis through actions on bacterial virulence factors[J].American Journal Physiology:Gastrointestinal and Liver Physiology,2008,294(1):G295-G306.
[10] SWIDSINSKI A,LOENING-BAUCKE V,VERSTRAELEN H,et al.Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea[J].Gastroenterology,2008,135(2):568-579.
[11] SCHNEIDER S M,GIRARD-PIPAU F,FILIPPI J,et al.Effects of
Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition[J].World Journal of Gastroenterology,2005,11(39):6165-6169.
[12] JAHN H U,ULLRICH R,SCHNEIDER T,et al.Immunological and trophical effects of
Saccharomyces boulardii on the small intestine in healthy human volunteers[J].Digestion,1996,57(2):95-104.
[13] BUTS J P,KEYSER N D,RAEDEMAEKER L D.
Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines[J].Pediatric Research,1994,36(4):522-527.
[14] MARTINS F S,VIEIRA A T,ELIAN S D A,et al.Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of
Saccharomyces boulardii against
Salmonella infection in mice[J].Microbes and Infection,2013,15(4):270-279.
[15] GENEROSO S V,VIANA M L,SANTOS R G,et al.Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed
Saccharomyces boulardii[J].European Journal of Nutrition,2011,50(4):261-269.
[16] MCFARLAND L V.Systematic review and meta-analysis of
Saccharomyces boulardii in adult patients[J].World Journal of Gastroenterology,2010,16(8):2202-2222.
[17] MCFARLAND L V,ELMER G W,MCFARLAND M.Meta-analysis of probiotics for the prevention and treatment of acute pediatric diarrhea[J].International Journal of Probiotics and Prebiotics,2006,1(1):63-76.
[18] CREMONINI F,DI CARO S,COVINO M,et al.Effect of different probiotic preparations on anti-
helicobacter pylori therapy-related side effects:a parallel group,triple blind,placebo-controlled study[J].The American Journal of Gastroenterology,2002,97(11):2744-2749.
[19] SZAJEWSKA H,HORVATH A,PIWOWARCZYK A.Meta-analysis:the effects of
Saccharomyces boulardii supplementation on
Helicobacter pylori eradication rates and side effects during treatment[J].Alimentary Pharmacology & Therapeutics,2010,32(9):1069-1079.
[20] RIAZ M,ALAM S,MALIK A,et al.Efficacy and safety of
Saccharomyces boulardii in acute childhood diarrhea:a double blind randomised controlled trial[J].The Indian Journal of Pediatrics,2012,79(4):478-482.
[21] MANSOUR-GHANAEI F,DEHBASHI N,YAZDANPARAST K,et al.Efficacy of
Saccharomyces boulardii with antibiotics in acute amoebiasis[J].World Journal of Gastroenterology,2003(9):1832-1833.
[22] MCFARLAND L V.Meta-analysis of probiotics for the prevention of traveler's diarrhea[J].Travel Medicine and Infectious Disease,2007,5(2):97-105.
[23] GUSLANDI M,MEZZI G,SORGHI M,et al.
Saccharomyces boulardii in maintenance treatment of Crohn's disease[J].Digestive Diseases and Sciences,2000,45(7):1462-1464.
[24] GARCIA VILELA E,DE LOURDES DE ABREU FERRARI M,OSWALDO DA GAMA TORRES H,et al.Influence of
Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission[J].Scandinavian Journal of Gastroenterology,2008,43(7):842-848.
[25] CHOI C H,JO S Y,PARK H J,et al.A randomized,double-blind,placebo-controlled multicenter trial of
Saccharomyces boulardii in irritable bowel syndrome:effect on quality of life[J].Journal of Clinical Gastroenterology,2011,45(8):679-683.
[26] MAUPAS J L,CHAMPEMONT P,DELFORGE M.Treatment of irritable bowel syndrome.Double blind trial of
Saccharomyces boulardii[J].Médecine & Chirurgie Digestives,1983,12(1):77-79.
[27] BESIRBELLIOGLU B A,ULCAY A,CAN M,et al.
Saccharomyces boulardii and infection due to
Giardia lamblia[J].Scandinavian Journal of Infectious Diseases,2006,38(6/7):479-481.
[28] SAINT-MARC T,BLEHAUT H,MUSIAL C,et al.Aids-related diarrhea:a double-blind trial of
Saccharomyces boulardii[J].Semaine des Hopitaux de Paris,1995,71(23):735-741.
[29] BONTEMPO V,DI GIANCAMILLO A,SAVOINI G,et al.Live yeast dietary supplementation acts upon intestinal morpho-functional aspects and growth in weanling piglets[J].Animal Feed Science and Technology,2006,129(3/4):224-236.
[30] BAUM B,LIEBLER-TENORIO E M,ENSS M L,et al.
Saccharomyces boulardii and
Bacillus cereus var.
Toyoi influence the morphology and the mucins of the intestine of pigs[J].Zeitschrift für Gastroenterologie,2002,40(5):277-284.
[31] COLLIER C T,CARROLL J A,BALLOU M A,et al.Oral administration of
Saccharomyces cerevisiae boulardii reduces mortality associated with immune and cortisol responses to
Escherichia coli endotoxin in pigs[J].Journal of Animal Science,2011,89(1):52-58.
[32] LESSARD M,DUPUIS M,GAGNON N,et al.Administration of
Pediococcus acidilactici or
Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after
Escherichia coli challenge[J].Journal of Animal Science,2009,87(3):922-934.
[33] WINCKLER C,SCHRODER B,BREVES G.Effects of
Saccharomyces boulardii,
Bacillus cereus var.
caron and
Bacillus cereus var.
toyoi on epithelial transport functions in pig jejunum[J].Zeitschrift für Gastroenterologie,1998,36(Suppl.1):30-37.
[34] BREVES G,WALTER C,BURMESTER M,et al.
In vitro studies on the effects of
Saccharomyces boulardii and
Bacillus cereus var.
toyoi on nutrient transport in pig jejunum[J].Journal of Animal Physiology and Animal Nutrition,2000,84(1/2):9-20.
[35] KAMM K,HOPPE S,BREVES G,et al.Effects of the probiotic yeast
Saccharomyces boulardii on the neurochemistry of myenteric neurones in pig jejunum[J].Neurogastroenterology & Motility,2004,16(1):53-60.
[36] RAJPUT I R,LI L Y,XIN X,et al.Effect of
Saccharomyces boulardii and
Bacillus subtilis B10 on intestinal ultrastructure modulation and mucosal immunity development mechanism in broiler chickens[J].Poultry Science,2013,92(4):956-965.
[37] HOOGE D M.Meta-analysis of broiler chicken pen trials evaluating dietary mannan oligosaccharide,1993—2003[J].International Journal of Poultry Science,2004,3(3):163-174.
[38] LINE J E,BAILEY J S,COX N A,et al.Effect of yeast-supplemented feed on
Salmonella and
Campylobacter populations in broilers[J].Poultry Science,1998,77(3):405-410.
[39] GIL DE LOS SANTOS J R,STORCH O B,GIL-TURNES C.
Bacillus cereus var.
toyoii and
Saccharomyces boulardii increased feed efficiency in broilers infected with
Salmonella enteritidis[J].British Poultry Science,2005,46(4):494-497.
[40] BRADLEY G L,SAVAGE T F,TIMM K I.The effects of supplementing diets with
Saccharomyces cerevisiae var.
boulardii on male poultry performance and ileal morphology[J].Poultry Science,1994,73(11):1766-1770.
[41] KEYSER S A,MCMENIMAN J P,SMITH D R,et al.Effects of
Saccharomyces cerevisiae subspecies
boulardii CNCM I-1079 on feed intake by healthy beef cattle treated with florfenicol and on health and performance of newly received beef heifers[J].Journal of Animal Science,2007,85(5):1264-1273.
[42] DAHIYA T,VERMA R K,SINGH G,et al.Elimination of pathogenic bacterium,
Aeromonas hydrophila by the use of probiotics[J].Journal of Fisheries Sciences,2012,6(3):209-214.
[43] SOUZA D M,MARTINS G B,PIEDRAS S R N,et al.Probiotic actions of
Bacillus cereus var.
toyoi and
Saccharomyces boulardii in silver catfish (
Rhamdia quelen) larvae culture[J].Revista Brasileira de Zootecnia,2012,41(3):815-819.
[44] SCHWENZER B.
Saccharomyces boulardii[J].Deutsche Apotheker-Zeitung,1998,138(11):75-77.
[45] SALMINEN M K,RAUTELIN H,TYNKKYNEN S,et al.
Lactobacillus bacteremia,species identification,and antimicrobial susceptibility of 85 blood isolates[J].Clinical Infectious Diseases,2006,42(5):e35-e44.
[46] KLEIN S M,ELMER G W,MCFARLAND L V,et al.Recovery and elimination of the biotherapeutic agent,
Saccharomyces boulardii,in healthy human volunteers[J].Pharmaceutical Research,1993,10(11):1615-1619.
京公网安备 11010802041926号